Corcept (CORT) director Leonard Baker Jr awarded 12,500 stock options

Rhea-AI Filing Summary

Corcept Therapeutics director Leonard G. Baker Jr received a grant of stock options covering 12,500 shares of common stock on May 21, 2026. The options have an exercise price of $59.69 per share and expire on May 21, 2036. They vest in equal monthly installments over one year starting on the monthly anniversary of May 21, 2026, contingent on his continued service, and represent equity-based compensation rather than an open-market trade.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider BAKER G LEONARD JR

Role null

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right To Buy)	12,500	$0.00	--

Holdings After Transaction: Stock Option (Right To Buy) — 12,500 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Options granted: 12,500 options Exercise price: $59.69 per share Underlying shares: 12,500 shares +3 more

6 metrics

Options granted 12,500 options Stock Option (Right To Buy) grant to director

Exercise price $59.69 per share Conversion or exercise price of option grant

Underlying shares 12,500 shares Common stock underlying the options

Grant date May 21, 2026 Transaction date for option award

Expiration date May 21, 2036 Option term end for this grant

Vesting schedule Monthly over one year From monthly anniversary of May 21, 2026, subject to service

Key Terms

Stock Option (Right To Buy), Grant, award, or other acquisition, exercise price, expiration date, +1 more

5 terms

Stock Option (Right To Buy) financial

"security_title: Stock Option (Right To Buy)"

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

exercise price financial

"conversion_or_exercise_price: 59.6900"

The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.

expiration date financial

"expiration_date: 2036-05-21T00:00:00.000Z"

The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.

vesting financial

"Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period"

Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

BAKER G LEONARD JR

(Last) (First) (Middle)

755 PAGE MILL ROAD

SUITE A-200

(Street)

PALO ALTO CALIFORNIA 94304-1005

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
CORCEPT THERAPEUTICS INC [ CORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/21/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right To Buy)	$59.69	05/21/2026		A		12,500		(1)	05/21/2036	Common Stock	12,500	$0	12,500	D

Explanation of Responses:

1. Exercisable ratably in equal installments on each monthly anniversary of May 21, 2026 over a one-year period, subject to the Reporting Person's continued service on each monthly vesting date.

	/s/ Kanwalpreet S. Kalra, by power of attorney	05/26/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did CORCEPT THERAPEUTICS INC (CORT) report for Leonard G. Baker Jr?

Corcept Therapeutics reported that director Leonard G. Baker Jr received a grant of 12,500 stock options. These options give him the right to buy common shares at a fixed exercise price as part of his equity compensation package.

What is the exercise price of Leonard G. Baker Jr’s new Corcept (CORT) stock options?

The granted stock options have an exercise price of $59.69 per share. This is the fixed price at which Baker can purchase Corcept common stock if and when he exercises the options in the future.

How many Corcept (CORT) shares are covered by Leonard G. Baker Jr’s option grant?

The option grant covers 12,500 underlying shares of Corcept common stock. Each option represents the right to buy one share at the stated exercise price once the option has vested and is exercisable.

When do Leonard G. Baker Jr’s Corcept (CORT) options vest and become exercisable?

The options vest in equal monthly installments over one year starting on the monthly anniversary of May 21, 2026. Vesting is conditioned on Baker’s continued service with Corcept on each monthly vesting date, according to the footnote.

What is the expiration date of Leonard G. Baker Jr’s Corcept (CORT) stock options?

The options expire on May 21, 2036. After that expiration date, any unexercised portion of the 12,500 options will no longer be usable, so exercise must occur before that deadline if they are vested.

Does Leonard G. Baker Jr’s Form 4 for Corcept (CORT) show a stock purchase or sale?

The Form 4 reflects a grant of stock options classified as an acquisition under code A, not an open-market purchase or sale. It represents compensation awarded by the company rather than a discretionary trade in Corcept shares.